| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |